Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Neurologia i Neurochirurgia Polska
MENU
Shortcuts Submit an article Guide for Authors Special collections Ahead Of Print Reviewers 2023

open access

Vol 57, No 3 (2023)
Guidelines
Submitted: 2022-11-16
Accepted: 2023-01-24
Published online: 2023-05-05
View PDF Download PDF file View HTML
Get Citation

Polish recommendations for diagnosis and therapy of paediatric stroke

Ewa Pilarska1, Ilona Kopyta2, Edyta Szurowska3, Julia Radoń-Proskura4, Ninela Irga-Jaworska4, Grzegorz Kozera5, Robert Sabiniewicz6, Ewa Emich-Widera2, Joanna Wojczal7
DOI: 10.5603/PJNNS.a2023.0034
·
Pubmed: 37144904
·
Neurol Neurochir Pol 2023;57(3):243-260.
Affiliations
  1. Department of Developmental Neurology, Department of Neurology, Medical University of Gdansk, Gdansk, Poland
  2. Department of Paediatric Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
  3. 2nd Department of Radiology, Faculty of Health Sciences, Medical University of Gdansk, Gdansk, Poland
  4. Department of Paediatric Hematology and Oncology , Medical University of Gdansk, Gdansk, Poland
  5. Medical Simulation Centre, Faculty of Medicine, Medical University of Gdansk, Poland and Department of Neurology, Copernicus Hospital, Gdansk, Poland
  6. Department of Paediatric Cardiology and Congenital Heart Disease, Medical University of Gdansk, Gdansk, Poland
  7. Department of Neurology, Medical University of Lublin, Lublin, Poland

open access

Vol 57, No 3 (2023)
Guidelines
Submitted: 2022-11-16
Accepted: 2023-01-24
Published online: 2023-05-05

Abstract

Stroke remains one of the greatest health challenges worldwide, due to a high mortality rate and, despite great progress in its treatment, the significant disability that it causes. Studies conducted around the world show that the diagnosis of stroke in children is often significantly delayed. Paediatric ischaemic arterial stroke (PAIS) is not only a problem that varies greatly in frequency compared to the adult population, it is also completely different in terms of its risk factors, clinical course and outcome. The main reason for the lack of a rapid diagnosis of PAIS is a lack of access to neuroimaging under general anaesthesia. The insufficient knowledge regarding PAIS in society as a whole is also of great importance. Parents and carers of children should always bear in mind that paediatric age is not a factor that excludes a diagnosis of stroke. The aim of this article was to develop recommendations for the management of children with acute neurological symptoms suspected of ischaemic stroke and further treatment after confirmation of the ischaemic aetiology of the problem. These recommendations are based on current global recommendations for the management of children with stroke, but our goal was also to match them as closely as possible to the needs and technical diagnostic and therapeutic possibilities encountered in Poland. Due to the multifactorial problem of stroke in children, not only paediatric neurologists but also a neurologist, a paediatric cardiologist, a paediatric haematologist and a radiologist took part in the preparation of these recommendations.

Abstract

Stroke remains one of the greatest health challenges worldwide, due to a high mortality rate and, despite great progress in its treatment, the significant disability that it causes. Studies conducted around the world show that the diagnosis of stroke in children is often significantly delayed. Paediatric ischaemic arterial stroke (PAIS) is not only a problem that varies greatly in frequency compared to the adult population, it is also completely different in terms of its risk factors, clinical course and outcome. The main reason for the lack of a rapid diagnosis of PAIS is a lack of access to neuroimaging under general anaesthesia. The insufficient knowledge regarding PAIS in society as a whole is also of great importance. Parents and carers of children should always bear in mind that paediatric age is not a factor that excludes a diagnosis of stroke. The aim of this article was to develop recommendations for the management of children with acute neurological symptoms suspected of ischaemic stroke and further treatment after confirmation of the ischaemic aetiology of the problem. These recommendations are based on current global recommendations for the management of children with stroke, but our goal was also to match them as closely as possible to the needs and technical diagnostic and therapeutic possibilities encountered in Poland. Due to the multifactorial problem of stroke in children, not only paediatric neurologists but also a neurologist, a paediatric cardiologist, a paediatric haematologist and a radiologist took part in the preparation of these recommendations.

Full Text:

View PDF Download PDF file View HTML
Get Citation

Keywords

stroke, paediatric, risk factors, diagnosis, treatment

About this article
Title

Polish recommendations for diagnosis and therapy of paediatric stroke

Journal

Neurologia i Neurochirurgia Polska

Issue

Vol 57, No 3 (2023)

Article type

Guidelines

Pages

243-260

Published online

2023-05-05

Page views

2011

Article views/downloads

982

DOI

10.5603/PJNNS.a2023.0034

Pubmed

37144904

Bibliographic record

Neurol Neurochir Pol 2023;57(3):243-260.

Keywords

stroke
paediatric
risk factors
diagnosis
treatment

Authors

Ewa Pilarska
Ilona Kopyta
Edyta Szurowska
Julia Radoń-Proskura
Ninela Irga-Jaworska
Grzegorz Kozera
Robert Sabiniewicz
Ewa Emich-Widera
Joanna Wojczal

References (110)
  1. Giroud M, Lemesle M, Madinier G, et al. Stroke in children under 16 years of age: Clinical and etiological difference with adults. Acta Neurol Scand. 1997;96:401-406, doi:10.1111/j.1600-0404.1997. tb00306, indexed in Pubmed. ; 9449480.
    CrossRef
  2. Felling RJ, Sun LR, Maxwell EC, et al. Pediatric arterial ischemic stroke: Epidemiology, risk factors, and management. Blood Cells Mol Dis. 2017; 67: 23–33.
    CrossRefPubMed
  3. Bernard TJ, Manco-Johnson MJ, Lo W, et al. Towards a consensus -based classification of childhood arterial ischemic stroke. Stroke. 2012;43(2):371-377, doi:10.1161/STROKEAHA. 111624585,indexed in Pubmed. ; 3312781.
    CrossRef
  4. Raju TNK, Nelson KB, Ferriero D, et al. NICHD-NINDS Perinatal Stroke Workshop Participants. Ischemic perinatal stroke: summary of a workshop sponsored by the National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke. Pediatrics. 2007; 120(3): 609–616.
    CrossRefPubMed
  5. Nelson KB, Lynch JK. Stroke in newborn infants. Lancet Neurol. 2004; 3(3): 150–158.
    CrossRefPubMed
  6. Daverio M, Bressan S, Gregori D, et al. Patient and Process Factors Associated With Type of First Neuroimaging and Delayed Diagnosis in Childhood Arterial Ischemic Stroke. Acad Emerg Med. 2016; 23(9): 1040–1047.
    CrossRefPubMed
  7. Mendley TL, Miteff Ch, Andrews I, et al. Australian clinical consensus guideline: The diagnosis and acute management of childhood stroke. Int J of Stroke. 2019;14(1):94-106. doi: 10. 11i7/1747493018799958indexed in Pubmed. ; 3028496.
  8. Rivkin MJ, Bernard TJ, Dowling MM, et al. Guidelines for Urgent Management of Stroke in Children. Pediatr Neurol. 2016; 56: 8–17.
    CrossRefPubMed
  9. Dowling MM, Hynan LS, Lo W, et al. International Paediatric Stroke Study Group. International Paediatric Stroke Study: stroke associated with cardiac disorders. Int J Stroke. 2013; 8 Suppl A100(Suppl A100): 39–44.
    CrossRefPubMed
  10. Graham ID, Harrison MB, Brouwers M, et al. Facilitating the use of evidence in practice: evaluating and adapting clinical practice guidelines for local use by health care organizations. J Obstet Gynecol Neonatal Nurs. 2002; 31(5): 599–611.
    CrossRefPubMed
  11. Amlie-Lefond C, Bernard TJ, Sébire G, et al. International Pediatric Stroke Study Group. Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke Study. Circulation. 2009; 119(10): 1417–1423.
    CrossRefPubMed
  12. Sébire G, Fullerton H, Riou E, et al. Toward the definition of cerebral arteriopathies of childhood. Curr Opin Pediatr. 2004; 16(6): 617–622.
    CrossRefPubMed
  13. Kirkham FJ, Hogan AM. Risk factors for arterial ischemic stroke in childhood. CNS Spectr. 2004; 9(6): 451–464.
    PubMed
  14. Aho K, Harmsen P, Hatano S, et al. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ. 1980; 58(1): 113–130.
    PubMed
  15. Fullerton HJ, Wu YW, Zhao S, et al. Risk of stroke in children: ethnic and gender disparities. Neurology. 2003; 61(2): 189–194.
    CrossRefPubMed
  16. Giroud M, Lemesle M, Gouyon JB, et al. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol. 1995; 48(11): 1343–1348.
    CrossRefPubMed
  17. Earley CJ, Kittner SJ, Feeser BR, et al. Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology. 1998; 51(1): 169–176.
    CrossRefPubMed
  18. Zahuranec DB, Brown DL, Lisabeth LD, et al. Is it time for a large, collaborative study of pediatric stroke? Stroke. 2005; 36(9): 1825–1829.
    CrossRefPubMed
  19. Schoenberg BS, Mellinger JF, Schoenberg DG. Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology. 1978; 28(8): 763–768.
    CrossRefPubMed
  20. Broderick J, Talbot GT, Prenger E, et al. Stroke in children within a major metropolita area: the suprising importance of intracerebral hemorrhage. J Child Neurol.1993;8:250-255.doi: 10. 1177/088307389300800308,indexed in Pubmed. ; 8409267.
    CrossRef
  21. Chung B, Wong V. Pediatric stroke among Hong Kong Chinese subjects. Pediatrics. 2004; 114(2): e206–e212.
    CrossRefPubMed
  22. deVeber GA, Kirton A, Booth FA, et al. Epidemiology and outcomes of arterial ischemic stroke in children: The Canadian Pediatric Ischemic Stroke Registry. Ped Neurol.2017;69:58-7, doi: 10.1016/j.pediatrneurol.2017.01. 016,indexed in Pubmed. ; 28254555.
    CrossRef
  23. Laugesaar R, Kolk A, Uustalu U, et al. Epidemiology of childhood stroke in Estonia. Pediatr Neurol. 2010; 42(2): 93–100.
    CrossRefPubMed
  24. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991; 337(8756): 1521–1526.
    CrossRefPubMed
  25. Tei H, Uchiyama S, Ohara K, et al. Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project. Stroke. 2000; 31(9): 2049–2054.
    CrossRefPubMed
  26. Pittock SJ, Meldrum D, Hardiman O, et al. The Oxfordshire Community Stroke Project classification: correlation with imaging, associated complications, and prediction of outcome in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2003; 12(1): 1–7.
    CrossRefPubMed
  27. Beslow LA, Dowling MM, Hassanein SMA, et al. International Pediatric Stroke Study Investigators. Mortality After Pediatric Arterial Ischemic Stroke. Pediatrics. 2018; 141(5).
    CrossRefPubMed
  28. Böhmer M, Niederstadt T, Heindel W, et al. Impact of Childhood Arterial Ischemic Stroke Standardized Classification and Diagnostic Evaluation Classification on Further Course of Arteriopathy and Recurrence of Childhood Stroke. Stroke. 2018 [Epub ahead of print]: STROKEAHA118023060.
    CrossRefPubMed
  29. Fullerton HJ, Stence N, Hills NK, et al. VIPS Investigators. Focal Cerebral Arteriopathy of Childhood: Novel Severity Score and Natural History. Stroke. 2018; 49(11): 2590–2596.
    CrossRefPubMed
  30. Lanthier S, Armstrong D, Domi T, et al. Post-varicella arteriopathy of childhood: natural history of vascular stenosis. Neurology. 2005; 64(4): 660–663.
    CrossRefPubMed
  31. Vázquez López M, de Castro de Castro P, Barredo Valderrama E, et al. Outcome of arterial ischemic stroke in children with heart disease. Eur J Paediatr Neurol. 2017; 21(5): 730–737.
    CrossRefPubMed
  32. Kopyta IA, Emich-Widera E, Balcerzyk A, et al. Polymorphisms of genes encoding coagulation factors II, V, VII, and XIII in relation to pediatric ischemic stroke: family-based and case-control study. Neurologist. 2012; 18(5): 282–286.
    CrossRefPubMed
  33. Pilarska E, Lemka M, Bakowska A. Prothrombotic risk factors in ischemic stroke and migraine in children. Acta Neurol Scand. 2006; 114(1): 13–16.
    CrossRefPubMed
  34. Sultan S, Dowling M, Kirton A, et al. IPSS Investigators. Dyslipidemia in Children With Arterial Ischemic Stroke: Prevalence and Risk Factors. Pediatr Neurol. 2018; 78: 46–54.
    CrossRefPubMed
  35. Recomendations RCPCH 2017. https://www.guidelines.co.uk/paediatrics/rcpch-stroke-in-childhood-guideline (15.12.2021).
  36. Ferriero DM, Fullerton HJ, Bernard TJ, et al. American Heart Association Stroke Council and Council on Cardiovascular and Stroke Nursing. Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association. Stroke. 2019; 50(3): e51–e96.
    CrossRefPubMed
  37. Mackay MT, Chua ZK, Lee M, et al. Stroke and nonstroke brain attacks in children. Neurology. 2014; 82(16): 1434–1440.
    CrossRefPubMed
  38. Rafay MF, Pontigon AM, Chiang J, et al. Delay to diagnosis in acute pediatric arterial ischemic stroke. Stroke. 2009;40(1); 58–64, doi: 10.1161/STROKEAHA. 108. 519066, indexed in Pubmed. ; 18802206.
    CrossRef
  39. Srinivasan J, Miller SP, Phan TG, et al. et al.. Delayed recognition of initial stroke in children: need for increased awareness. Pediatrics. 2009;124(2); 227–234, doi: 10.1542/peds.2008-3544. indexed in Pubmed. ; 19620205.
    CrossRef
  40. Cortnum S, Sørensen P, Jørgensen J. Determining the sensitivity of computed tomography scanning in early detection of subarachnoid hemorrhage. Neurosurgery. 2010;66(5):900–902; discussion 903. indexed in Pubmed. ; 20404693.
  41. Karttunen AI, Jartti PH, Ukkola VA, et al. Value of the quantity and distribution of subarachnoid haemorrhage on CT in the localization of a ruptured cerebral aneurysm. Acta Neurochir (Wien). 2003; 145(8): 655–61; discussion 661.
    CrossRefPubMed
  42. Mitchell P. Detection of subarachnoid haemorrhage with magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 2001;70(2):205–11, ; doi: 10.1136/jnnp.70.2.205. ,indexed in Pubmed. ; 11160469.
    CrossRef
  43. Heit JJ, Iv M, Wintermark M. Imaging of Intracranial Hemorrhage. J Stroke. 2017;19(1):11–27, doi : 10.5853/jos.2016. 00563,indexed in Pubmed. ; 28030895.
    CrossRef
  44. Kumar S, Goddeau RP, Selim MH, et al. Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies. Neurology. 2010; 74(11): 893–899.
    CrossRefPubMed
  45. Rafay MF, Pontigon AM, Chiang J, et al. Delay to diagnosis in acute pediatric arterial ischemic stroke. Stroke. 2009; 40(1): 58–64.
    CrossRefPubMed
  46. Mallick AA, Ganesan V, Kirkham FJ, et al. Diagnostic delays in paediatric stroke. J Neurol Neurosurg Psychiatry. 2015; 86(8): 917–921.
    CrossRefPubMed
  47. Daverio M, Bressan S, Gregori D, et al. Patient and Process Factors Associated With Type of First Neuroimaging and Delayed Diagnosis in Childhood Arterial Ischemic Stroke. Acad Emerg Med. 2016; 23(9): 1040–1047.
    CrossRefPubMed
  48. Srinivasan J, Miller SP, Phan TG, et al. Delayed recognition of initial stroke in children: need for increased awareness. Pediatrics. 2009; 124(2): e227–e234.
    CrossRefPubMed
  49. Shack M, Andrade A, Shah-Basak PP, et al. Acute Stroke Protocol study group. A pediatric institutional acute stroke protocol improves timely access to stroke treatment. Dev Med Child Neurol. 2017; 59(1): 31–37.
    CrossRefPubMed
  50. DeLaroche AM, Sivaswamy L, Farooqi A, et al. Pediatric Stroke Clinical Pathway Improves the Time to Diagnosis in an Emergency Department. Pediatr Neurol. 2016; 65: 39–44.
    CrossRefPubMed
  51. Zuccoli G, Fitz C, Greene S, et al. Imaging Review of Common and Rare Causes of Stroke in Children. Top Magn Reson Imaging. 2018; 27(6): 463–477.
    CrossRefPubMed
  52. Bergen DC, Rayman L, Heydemann P. Bilateral Todd's paralysis after focal seizures. Epilepsia. 1992; 33(6): 1101–1105.
    CrossRefPubMed
  53. Powers W, et al. Cerebral blood flow and metabolism: regulation and pathophysiology in cerebral disease. In: Grotta J, Stroke. Pathophysiology. Diagnosis and Management. Sixth ed. : Elsevier.
  54. Mackay MT, Wiznitzer M, Benedict SL, et al. International Pediatric Stroke Study Group. Arterial ischemic stroke risk factors: the International Pediatric Stroke Study. Ann Neurol. 2011; 69(1): 130–140.
    CrossRefPubMed
  55. Vu D, Lev MH. Noncontrast CT in acute stroke. Semin Ultrasound CT MR. 2005; 26(6): 380–386.
    CrossRefPubMed
  56. Mirsky DM, Beslow LA, Amlie-Lefond C, et al. International Paediatric Stroke Study Neuroimaging Consortium and the Paediatric Stroke Neuroimaging Consortium. Pathways for Neuroimaging of Childhood Stroke. Pediatr Neurol. 2017; 69: 11–23.
    CrossRefPubMed
  57. Broocks G, Uta Ha, Flottmann F. et. al. Clinical benefit of thrombectomy in stroke patients with low ASPECTS is mediated by oedema reduction, Brain, 2019, 142, (5), 1399–1407, doi : 10. 1093/brain/awz057,indexed in Pubmed. ; 30859191.
    CrossRef
  58. Merino JG, Warach S. Imaging of acute stroke. Nat Rev Neurol. 2010; 6(10): 560–571.
    CrossRefPubMed
  59. Muir KW, Buchan A, von Kummer R, et al. Imaging of acute stroke. Lancet Neurol. 2006; 5(9): 755–768.
    CrossRefPubMed
  60. Stuckey SL, Goh TD, Heffernan T, et al. Hyperintensity in the subarachnoid space on FLAIR MRI. AJR Am J Roentgenol. 2007; 189(4): 913–921.
    CrossRefPubMed
  61. Remonda L, Senn P, Barth A, et al. Contrast-enhanced 3D MR angiography of the carotid artery: comparison with conventional digital subtraction angiography. AJNR Am J Neuroradiol. 2002; 23(2): 213–219.
    PubMed
  62. deVeber G, Andrew M, Adams C, et al. Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001; 345(6): 417–423.
    CrossRefPubMed
  63. Saposnik G, Barinagarrementeria F, Brown RD, et al. American Heart Association Stroke Council and the Council on Epidemiology and Prevention. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42(4): 1158–1192.
    CrossRefPubMed
  64. Ferro JM, Canhao P, Stam J, et al. Investigators ISCVT Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 35:664–670, doi: 10.11161/01.STR.000011757176 197.26. indexed in Pubmed. 2004; 14976332.
    CrossRef
  65. Mattle HP, Arnold M, Lindsberg PJ, et al. Basilar artery occlusion. Lancet Neurol. 2011; 10(11): 1002–1014.
    CrossRefPubMed
  66. Gonzalez RG, et al. Acute ischemic stroke: imaging and intervention. Second edition. Springer, New York, NY. ; 2011.
  67. Ladner TR, Mahdi J, Gindville MC, et al. Pediatric Acute Stroke Protocol Activation in a Children's Hospital Emergency Department. Stroke. 2015; 46(8): 2328–2331.
    CrossRefPubMed
  68. Shellhaas RA, Smith SE, O'Tool E, et al. Mimics of childhood stroke: characteristics of a prospective cohort. Pediatrics. 2006; 118(2): 704–709.
    CrossRefPubMed
  69. Mattle HP, Arnold M, Lindsberg PJ, et al. Basilar artery occlusion. Lancet Neurol. 2011; 10(11): 1002–1014.
    CrossRefPubMed
  70. Chalmers E, Ganesen V, Liesner Ri, et al. British Committee for Standards in Haematology. Guideline on the investigation, management and prevention of venous thrombosis in children. Br J Haematol. 2011; 154(2): 196–207.
    CrossRefPubMed
  71. Monagle P, Chan AKC, Goldenberg NA, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl): e737S–e801S.
    CrossRefPubMed
  72. Andrade A, Dlamini N, Williams S, et al. Pediatric Stroke. W: Blanchette VS, ‎Brandão LR, ‎Breakey VR, Revel-Vilk S. SickKids Handbook of Pediatric Thrombosis and Hemostasis. Basel; New York: Karger. ; 2017: 217–235.
  73. Sosothikul D, Seksarn P, Lusher JM. Pediatric reference values for molecular markers in hemostasis. J Pediatr Hematol Oncol. 2007; 29(1): 19–22.
    CrossRefPubMed
  74. Zawilska K. Trombofilie wrodzone i nabyte. W: Dmoszyńska A (red).Hematologia. Warszawa, Medical Tribune Polska. ; 2011: 631–42.
  75. Rizzi M, Barnes ChA. Diagnostic. Approach to a Child with Thrombosis. W: Blanchette VS, ‎Brandão LR, ‎Breakey VR, Revel-Vilk S. SickKids Handbook of Pediatric Thrombosis and Hemostasis. Basel; New York: Karger. ; 2017: 157–174.
  76. Baglin T, Gray E, Greaves M, et al. British Committee for Standards in Haematology. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010; 149(2): 209–220.
    CrossRefPubMed
  77. Ehrenforth S, Junker R, Koch HG, et al. Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. Childhood Thrombophilia Study Group. Eur J Pediatr. 1999; 158 Suppl 3: S97–104.
    CrossRefPubMed
  78. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306, doi: 10.1111/j.1538-7836.2006.01753.x. indexed in Pubmed. ; 16420554.
    CrossRef
  79. Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019; 78(10): 1296–1304.
    CrossRefPubMed
  80. Soybilgic A, Avcin T. Pediatric APS: State of the Art. Curr Rheumatol Rep. 2020; 22(3): 9.
    CrossRefPubMed
  81. Avcin T, Cimaz R, Silverman ED, et al. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. Pediatrics. 2008; 122(5): e1100–e1107.
    CrossRefPubMed
  82. Boffa MC, Lachassinne E. Infant perinatal thrombosis and antiphospholipid antibodies: a review. Lupus. 2007; 16(8): 634–641.
    CrossRefPubMed
  83. Smith OP. Thrombotic disorders. W: Smith OP, Hann IM (red). Essential paediatric haematology London, M Dunitz. ; 2002: 131–140.
  84. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood. 1987; 70(1): 165–172.
    PubMed
  85. Andrew M, Vegh P, Johnston M, et al. Maturation of the hemostatic system during childhood. Blood. 1992; 80(8): 1998–2005.
    PubMed
  86. Alexandrov AV. Cerebrovascular Ultrasound in Stroke Prevention and Treatment. 2 nd Edition. ; 2011.
  87. Bartels E. Color-Coded Duplex Ultrasonography of the cerebral Vessels. 2 nd Edition. Schattauer Verlagsgeselshaft, Stuttgart, New York. ; 2018.
  88. Dowling MM, Hynan LS, Lo W, et al. International Paediatric Stroke Study Group. International Paediatric Stroke Study: stroke associated with cardiac disorders. Int J Stroke. 2013; 8 Suppl A100(Suppl A100): 39–44.
    CrossRefPubMed
  89. Cao GF, Bi Qi. Pediatric Infective Endocarditis and Stroke: A 13-Year Single-Center Review. Pediatr Neurol. 2019; 90: 56–60.
    CrossRefPubMed
  90. Lanz J, Brophy JM, Therrien J, et al. Stroke in Adults With Congenital Heart Disease: Incidence, Cumulative Risk, and Predictors. Circulation. 2015; 132(25): 2385–2394.
    CrossRefPubMed
  91. Fox CK, Sidney S, Fullerton HJ. Community-based case-control study of childhood stroke risk associated with congenital heart disease. Stroke. 2015; 46(2): 336–340.
    CrossRefPubMed
  92. Mandalenakis Z, Rosengren A, Lappas G, et al. Ischemic Stroke in Children and Young Adults With Congenital Heart Disease. J Am Heart Assoc. 2016; 5(2).
    CrossRefPubMed
  93. Goldenberg NA, Bernard TJ. Venous thromboembolism in children. Hematol Oncol Clin North Am. 2010; 24(1): 151–166.
    CrossRefPubMed
  94. Benedik MP, Zaletel M, Meglic NP, et al. Patent foramen ovale and unexplained ischemic cerebrovascular events in children. Catheter Cardiovasc Interv. 2007; 70(7): 999–1007.
    CrossRefPubMed
  95. Agnetti A, Carano N, Sani E, et al. Cryptogenic stroke in children: possible role of patent foramen ovale. Neuropediatrics. 2006; 37(1): 53–56.
    CrossRefPubMed
  96. Bartz PJ, Cetta F, Cabalka AK, et al. Paradoxical emboli in children and young adults: role of atrial septal defect and patent foramen ovale device closure. Mayo Clin Proc. 2006; 81(5): 615–618.
    CrossRefPubMed
  97. Wawrzyńczyk M, Gałeczka M, Karwot B, et al. Efficiency of transcatheter patent foramen ovale closure in children after paradoxical embolism events. Kardiol Pol. 2016; 74(4): 385–389.
    CrossRefPubMed
  98. White RI, et al. Jr., Lynch-Nyhan A, Terry P, Pulmonary arteriovenous malformations:techniques and long-term outcome of embolotherapy. Radiology1988;169:663–9. doi: 10.1148/radiology.169.3.186989. indexed in Pubmed. ; 3186989.
    CrossRef
  99. Schechter T, Kirton A, Laughlin S, et al. Safety of anticoagulants in children with arterial ischemic stroke. Blood. 2012; 119(4): 949–956.
    CrossRefPubMed
  100. Kirton A, Armstrong-Wells J, Chang T, et al. International Pediatric Stroke Study Investigators. Symptomatic neonatal arterial ischemic stroke: the International Pediatric Stroke Study. Pediatrics. 2011; 128(6): e1402–e1410.
    CrossRefPubMed
  101. Beslow LA, Smith SE, Vossough A, et al. Hemorrhagic transformation of childhood arterial ischemic stroke. Stroke. 2011; 42(4): 941–946.
    CrossRefPubMed
  102. Pengo V, Denas G, Zoppellaro G, et al. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood. 2018; 132(13): 1365–1371.
    CrossRefPubMed
  103. Rizzi M, Barnes ChA. Diagnostic Approach to a Child with Thrombosis. W: Blanchette VS, ‎Brandão LR, ‎Breakey VR, Revel-Vilk S. SickKids Handbook of Pediatric Thrombosis and Hemostasis. Basel; New York: Karger. ; 2017: 157–174.
  104. Sträter R, Kurnik K, Heller C, et al. Aspirin versus low-dose low-molecular-weight heparin: antithrombotic therapy in pediatric ischemic stroke patients: a prospective follow-up study. Stroke. 2001; 32(11): 2554–2558.
    CrossRefPubMed
  105. Dangas GD, Tijssen JGP, Wöhrle J, et al. GALILEO Investigators. A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. N Engl J Med. 2020; 382(2): 120–129.
    CrossRefPubMed
  106. Kozera G, Sobolewski P, Serafin Z. Doświadczenie dwóch dekad leczenia trombolitycznego udaru niedokrwiennego mózgu : aktualne pytania i odpowiedzi. Gdańsk: Wydaw AsteriaMed. ; 2017.
  107. Powers WJ, Rabinstein AA, Ackerson T, et al. American Heart Association Stroke Council. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018; 49(3): e46–e4e110.
    CrossRefPubMed
  108. Rivkin MJ, deVeber G, Ichord RN, et al. Thrombolysis in pediatric stroke study. Stroke. 2015; 46(3): 880–885.
    CrossRefPubMed
  109. Charakterystyka produktu leczniczego. http://www.boehringer-ingelheim.pl/sites/pl/files/documents/poland_pdf/actilyse_20_chpl2019.pdf (07.04.2023).
  110. Beslow LA, Kasner SE, Smith SE, et al. Concurrent validity and reliability of retrospective scoring of the Pediatric National Institutes of Health Stroke Scale. Stroke. 2012; 43(2): 341–345.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl